Skip to main content
TipRanks
Go Ultimate75% OFF

Dr. Hoenle AG (HNL) Stock Price & Analysis

1 Followers

HNL Stock Chart & Stats

€7.46-€0.14(-1.84%)
At close: 5:30 PM GMT+1
€7.25€7.5€7.75€8Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
EUR 7.46 - EUR 7.58
52-Week Range
EUR 6.48 - EUR 10.40
Previous Close
EUR 7.60
Volume
N/A
Average Volume (3M)
1,346
Market Cap
EUR 46.07M
Enterprise Value
EUR 91.43M
Total Cash (Recent Filing)
EUR 7.23M
Total Debt (Recent Filing)
EUR 46.62M
Price to Earnings (P/E)
―
Beta
0.79
Next Earnings
Dec 08, 2026 (Est.)
EPS Estimate
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Rebound

The sharp TTM revenue rebound indicates renewed demand for Hönle’s industrial UV and LED solutions and provides a stronger base for operating leverage. If sales momentum persists, the enlarged revenue base could support better utilization, product investment, and eventual margin recovery.

Positive Cash Generation

Positive operating and free cash flow gives Hönle internal funding for product development, customer support, and investment without relying entirely on external capital. This cash generation is a meaningful financial strength while management works to convert revenue growth into durable earnings.

Recurring Aftermarket Model

An installed base of UV and LED systems can generate recurring replacement, maintenance, measurement, and support revenue beyond initial equipment sales. That aftermarket element can deepen customer relationships, improve revenue visibility, and provide resilience as customers’ production lines operate over time.

Bears Say

Severe Margin Pressure

The collapse in gross margin shows that the strong sales rebound has not yet translated into attractive economics. Persistently negative net income limits reinvestment capacity and leaves the business dependent on a successful margin recovery before growth can produce durable shareholder returns.

Volatile Cash Conversion

Current cash generation is encouraging, but the history of negative free cash flow and weak operating cash flow indicates that conversion has not been consistently dependable. Such volatility can complicate investment planning and reduce the financial cushion available during weaker operating periods.

Unfinished Profitability Turnaround

Consistently negative returns on equity indicate that the company has not yet generated satisfactory profits from its capital base. The extended history of losses suggests the recent improvement is still an incomplete turnaround, leaving long-term financial strength reliant on sustained earnings normalization.

Dr. Hoenle AG News

HNL FAQ

What was Dr. Hoenle AG’s price range in the past 12 months?
Dr. Hoenle AG lowest stock price was €6.48 and its highest was €10.40 in the past 12 months.
What is Dr. Hoenle AG’s market cap?
Dr. Hoenle AG’s market cap is €46.07M.
When is Dr. Hoenle AG’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Dr. Hoenle AG’s earnings last quarter?
Dr. Hoenle AG released its earnings results on Aug 18, 2026. The company reported -€0.04 earnings per share for the quarter.
Is Dr. Hoenle AG overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Dr. Hoenle AG pay dividends?
Dr. Hoenle AG pays an annual dividend of €0.2 which represents an annual dividend yield of ―. See more information on Dr. Hoenle AG dividends here
What is Dr. Hoenle AG’s EPS estimate?
Dr. Hoenle AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dr. Hoenle AG have?
Dr. Hoenle AG has 6,062,930 shares outstanding.
What happened to Dr. Hoenle AG’s price movement after its last earnings report?
Dr. Hoenle AG reported an EPS of -€0.04 in its last earnings report. Following the earnings report the stock price went up 1.259%.
Which hedge fund is a major shareholder of Dr. Hoenle AG?
Currently, no hedge funds are holding shares in DE:HNL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology